Abstract:
PURPOSE:To evaluate dosimetry and source location relative to CT-based dosimetry when performing real-time dynamic permanent prostate brachytherapy (PPB) with inverse treatment planning. METHODS AND MATERIALS:A treatment algorithm for dynamic PPB was developed using inverse treatment planning. The technique utilizes real-time transrectal ultrasound prostate imaging connected to the treatment planning software. The implementation of the plan with the Mick interstitial gun is monitored with up-to-date dosimetry assessments based on the registration of each seed when placed. Real-time dose assessment is monitored and adjustments can be made during the case, if necessary. A final OR dosimetric (OR-D) assessment based on the registered seed locations is performed. Postoperative CT scans obtained at 3 weeks are used for traditional dosimetry analysis (CT-D). A matrix algorithm was developed to match the seed locations from the ultrasound registration to that of the CT-scan parameters. RESULTS:Twenty-six consecutive patients with clinically localized prostate cancer underwent PPB using the algorithm designed for dynamic real-time planning. The OR-D identified a mean D90 of 109% (range 100-118%) whereas the mean CT-D D90 at 3 weeks was 105% (range 89-122%) (p=0.894). Analysis of the OR-D V100 and V150 relative to the 3-week CT-dose V100 and V150 were also insignificant (p=0.112 and 0.167, respectively). Assessment of seed locations relative to the intraoperative ultrasound and postimplant CT identified a mean root-mean-square error of 4.6 mm (0-21 mm). The mean error for the x, y, and z coordinates were 2.01 mm, 2.24 mm, and 2.85 mm, respectively. CONCLUSIONS:This study reports the preliminary results of a new treatment algorithm for PPB that incorporates intraoperative inverse planning with dynamic dosimetry assessment during the case. Correlation was seen between the completed intraoperative, postimplant plan and the CT based plan at 3 weeks. Seed to seed deviations between the OR-D matched well with the CT-D. Additional study is necessary to assess whether this approach can assist in improving implant dosimetry and whether it appropriately documents the OR-dose without the need for postimplant dosimetry.
journal_name
Brachytherapyjournal_title
Brachytherapyauthors
Potters L,Calguaru E,Thornton KB,Jackson T,Huang Ddoi
10.1016/S1538-4721(03)00134-Xkeywords:
subject
Has Abstractpub_date
2003-01-01 00:00:00pages
172-80issue
3eissn
1538-4721issn
1873-1449pii
S153847210300134Xjournal_volume
2pub_type
杂志文章相关文献
Brachytherapy文献大全abstract:PURPOSE:Brachytherapy (BrT) is a standard treatment for low-risk to favorable-intermediate-risk prostate cancer but is a relative contraindication for patients with obstructive symptoms. We aimed to assess the feasibility and urinary toxicity of a minimal photovaporization (mPVP) before implantation. MATERIALS AND MET...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2020.08.003
更新日期:2021-01-01 00:00:00
abstract:PURPOSE:Brachytherapy re-irradiation may offer an alternative re-treatment of recurrent head-and-neck cancer even after previous full dose radiation therapy. The purposes of this study were to determine the feasibility and accuracy of frameless image-guided interstitial needle implantation. METHODS AND MATERIALS:Betwe...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2005.02.001
更新日期:2005-01-01 00:00:00
abstract:PURPOSE:Dose escalation has been shown beneficial in prostate cancer. Brachytherapy (BT) provides an opportunity for dose escalation beyond what can be safely delivered using only teletherapy methods. The purpose of this study was to determine cancer control and morbidity of external beam radiation therapy (EBRT) plus ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2009.01.002
更新日期:2009-04-01 00:00:00
abstract:PURPOSE:To develop a safe and robust workflow for yttrium-90 (Y-90) radioembolization procedures in a multidisciplinary team environment. METHODS AND MATERIALS:A generalized Define-Measure-Analyze-Improve-Control (DMAIC)-based approach to process improvement was applied to a Y-90 radioembolization workflow. In the fir...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.08.001
更新日期:2017-01-01 00:00:00
abstract:OBJECTIVES:Men with higher body mass index (BMI) tend to have more fatty tissue in prostate-rectum interface, which may reduce the rectal wall dose by the inverse square law. We hypothesized that men with higher BMI will have a lower dose to the rectal wall and less rectal toxicity after permanent prostate implant. ME...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2008.12.001
更新日期:2009-04-01 00:00:00
abstract:PURPOSE:To identify patients at extremely low risk of biochemical recurrence (BCR) of prostate cancer after low-dose-rate brachytherapy (LDR-BT) to determine when prostate-specific antigen (PSA) monitoring can be stopped. METHODS AND MATERIALS:We retrospectively reviewed clinicopathologic data of patients with prostat...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2018.08.018
更新日期:2018-01-01 00:00:00
abstract:PURPOSE:To evaluate the clinical outcomes of women receiving a "short" course of high-dose-rate gynecologic interstitial brachytherapy (HDR-ISBT) boost with CT-based 3D planning. METHODS AND MATERIALS:Forty-seven women with no prior radiation received HDR-ISBT from August 2004 to February 2012. The mean external beam ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.02.001
更新日期:2014-05-01 00:00:00
abstract:PURPOSE:To assess the feasibility and tumor outcome of re-irradiation with low-dose-rate brachytherapy for macroscopic local recurrences after radical prostatectomy (RP) followed by adjuvant or salvage external beam radiation therapy (EBRT). METHODS AND MATERIALS:Between 2011 and 2018, five men with histologically pro...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2020.07.001
更新日期:2021-01-01 00:00:00
abstract:PURPOSE:Patients with cervical and vaginal cancer sometimes have a less straightforward approach for choice of brachytherapy treatment owing to the tumor's location and clinical presentation. The staff at Royal Brisbane & Women's Hospital in Queensland, Australia, is trying to solve this problem by the use of an old te...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.10.004
更新日期:2015-03-01 00:00:00
abstract:PURPOSE:Describe the incidence and identify risk factors for seroma development after MammoSite breast brachytherapy (MBT). METHODS AND MATERIALS:MBT patient data were prospectively recorded into a quality assurance database. Departmental and electronic records were reviewed to extract patient-, treatment-, and outcom...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2008.07.001
更新日期:2008-10-01 00:00:00
abstract:PURPOSE:Accelerated partial breast irradiation (APBI) continues to increase in popularity. Up to 14% of patients treated with the MammoSite (MS) report some degree of chronic pain, which may be related to chest wall toxicity. Reports from several institutions using the multicatheter (MC) technique have not shown associ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2008.11.007
更新日期:2009-04-01 00:00:00
abstract:PURPOSE:To describe in detail British Columbia (BC) Cancer Agency (BCCA) Provincial Prostate Brachytherapy (PB) Quality Assurance (QA) Program. METHODS AND MATERIALS:The BCCA PB Program was established in 1997. It operates as one system, unified and supported by electronic and information systems, making it a single P...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2012.03.006
更新日期:2013-07-01 00:00:00
abstract:PURPOSE:To present a clinical procedure that readjusts catheters to its planned positions based on pretreatment computed tomography (CT) for patients undergoing high-dose-rate (HDR) prostate brachytherapy, and evaluate the magnitude and dosimetric impact of the adjustments. METHODS AND MATERIALS:Patients received a pr...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2012.08.008
更新日期:2013-05-01 00:00:00
abstract:OBJECTIVE:To compare dosimetrically the stereotactic CyberKnife (CK) therapy and multicatheter high-dose-rate (HDR) brachytherapy (BT) for accelerated partial breast irradiation (APBI). METHODS:Treatment plans of 25 patients treated with CK were selected, and additional plans using multicatheter HDR BT were created on...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2020.10.003
更新日期:2020-11-18 00:00:00
abstract:PURPOSE:To present recommendations for the use of brachytherapy (BT) in patients with soft tissue sarcoma (STS). METHODS:A group of practitioners with expertise and experience in sarcoma BT formulated recommendations for BT in STS based on clinical experience and literature review. RESULTS:The indications for adjuvan...
journal_title:Brachytherapy
pub_type: 杂志文章,评审
doi:10.1016/j.brachy.2012.12.002
更新日期:2013-05-01 00:00:00
abstract:PURPOSE:Ostial restenosis is a common cause of failures in paranasal sinus surgery. The aim of the current study was to investigate the use of low-dose-rate brachytherapy to prevent neo-ostial restenosis in an animal model. METHODS AND MATERIALS:In 14 rabbits, maxillary neo-ostia were created and measured. One side ea...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.08.011
更新日期:2017-01-01 00:00:00
abstract:UNLABELLED:PURPOSE/INTRODUCTION: To safely irradiate retroperitoneal targets as paraaortic lymph node by separating abdominal at-risk organs from the target during irradiation, we created a percutaneous paravertebral approach of high-dose-rate brachytherapy with hyaluronate gel injection (HGI). We report a case treated...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2011.12.004
更新日期:2013-01-01 00:00:00
abstract:INTRODUCTION:Substantial as opposed to focal or no lymphovascular space invasion (LVSI) is proposed as an independent adverse prognostic factor in patients with early-stage endometrioid endometrial cancer (EEC). We reviewed outcomes of patients treated with adjuvant vaginal brachytherapy (VB) alone in a single institut...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2020.12.006
更新日期:2021-01-20 00:00:00
abstract:PURPOSE:To compare dose-volume histogram variables for the internal and external urinary sphincters (IUS/EUS) with urinary quality of life after prostate brachytherapy. METHODS AND MATERIALS:Subjects were 42 consecutive men from a prospective study of brachytherapy as monotherapy with (125)I for intermediate-risk loca...
journal_title:Brachytherapy
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.brachy.2012.10.006
更新日期:2013-05-01 00:00:00
abstract:PURPOSE:The aim of this study was to estimate the incidence of complications after (90)Y microsphere radioembolization for unresectable hepatic tumors and evaluate risk factors for late complications. METHODS AND MATERIALS:A cohort of 112 consecutive patients from two institutions underwent (90)Y microsphere radioembo...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2013.05.008
更新日期:2013-11-01 00:00:00
abstract:PURPOSE:The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS:Monte Carlo...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2011.11.005
更新日期:2012-11-01 00:00:00
abstract:PURPOSE:The available data demonstrating that superiority of LDR brachytherapy (LDR-BT) boost in high-risk prostate cancer patients under represents patients with extracapsular extension (T3a) and/or seminal vesicle invasion (T3b) have been limited. We report long-term clinical outcomes data for patients with cT3a/b di...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2018.07.001
更新日期:2018-01-01 00:00:00
abstract:PURPOSE:The study aimed to evaluate mature outcomes of a Phase I/II high-dose-rate brachytherapy (HDRB) boost protocol. METHODS AND MATERIALS:We analyzed data from 88 patients with T1a-T3a, N0, M0 prostate adenocarcinoma treated on a prospective Phase I/II HDRB boost protocol of 16 (n = 47) or 20 Gy (n = 41) in four f...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2006.08.007
更新日期:2006-10-01 00:00:00
abstract:PURPOSE:Androgen deprivation therapy (ADT) has been shown to improve survival for men with unfavorable-risk prostate cancer (PCa). We investigated the utilization and factors associated with the omission of ADT in radiation-managed high-risk PCa. METHODS AND MATERIALS:We used the National Cancer Database to identify m...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.07.001
更新日期:2016-01-01 00:00:00
abstract:PURPOSE:Although current Delphi Consensus guidelines do not recommend a specific definition of biochemical recurrence after partial gland therapy, these guidelines acknowledge that serial prostate-specific antigen (PSA) tests remain the best marker for monitoring disease after treatment. The purpose of this study was t...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2018.12.001
更新日期:2019-01-01 00:00:00
abstract:PURPOSE:To explore the dosimetric advantage of target volume and surrounding normal tissue by using interstitial (IS) brachytherapy (BT) based on three-dimensional CT in locally advanced cervical cancer, as a simple and effective clinical treatment approach. METHODS AND MATERIALS:Fifty-two patients with poor tumor res...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.06.004
更新日期:2016-09-01 00:00:00
abstract:OBJECTIVE:To determine the usefulness of prostate-specific antigen (PSA) percentage (vs. pretreatment value assumed as 100%) in prediction of biochemical relapse, after iodine-125 ((125)I) permanent brachytherapy for prostate cancer, to employ a parameter independent by the initial PSA amount and by the individual pros...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2011.08.008
更新日期:2012-07-01 00:00:00
abstract:PURPOSE:Accurate patient-specific dosimetry in intravascular brachytherapy (IVBT) is generally difficult due to the extremely high-dose gradient, complexity of treatment device, and patient-specific geometry (e.g., calcification, stent, curvature, movement of target). The purpose of this study is to analyze quantitativ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2005.07.004
更新日期:2005-01-01 00:00:00
abstract:OBJECTIVES:To evaluate the interim outcomes of low-dose-rate permanent brachytherapy (PB) combined with short-term androgen deprivation therapy (ADT) in Japanese men with intermediate-risk prostate cancer excluding those with a Gleason score of 4+3. METHODS:The Protocol-intermediate-risk group (Protocol-IRG) was defin...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.09.001
更新日期:2015-03-01 00:00:00
abstract:PURPOSE:To assess the toxicity and efficacy of salvage wide resection (SWR) with intraoperative electron beam radiation therapy (IOERT) or perioperative high-dose-rate brachytherapy (PHDRB) in previously unirradiated patients (PUP) vs. previously irradiated patients (PIP) with isolated local recurrence of soft tissue s...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.09.003
更新日期:2015-01-01 00:00:00